- Home
- ONMD vs ADAG Comparison
ONMD vs ADAG Comparison
Compare ONMD & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- ADAG
- Stock Information
- Founded
- ONMD 2006
- ADAG 2011
- Country
- ONMD United States
- ADAG China
- Employees
- ONMD N/A
- ADAG N/A
- Industry
- ONMD
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- ONMD
- ADAG Health Care
- Exchange
- ONMD Nasdaq
- ADAG Nasdaq
- Market Cap
- ONMD 71.4M
- ADAG 84.8M
- IPO Year
- ONMD N/A
- ADAG 2021
- Fundamental
- Price
- ONMD $1.33
- ADAG $1.84
- Analyst Decision
- ONMD
- ADAG Strong Buy
- Analyst Count
- ONMD 0
- ADAG 4
- Target Price
- ONMD N/A
- ADAG $8.00
- AVG Volume (30 Days)
- ONMD 770.9K
- ADAG 84.8K
- Earning Date
- ONMD 11-14-2025
- ADAG 08-12-2025
- Dividend Yield
- ONMD N/A
- ADAG N/A
- EPS Growth
- ONMD N/A
- ADAG N/A
- EPS
- ONMD N/A
- ADAG N/A
- Revenue
- ONMD $494,000.00
- ADAG $103,204.00
- Revenue This Year
- ONMD N/A
- ADAG $7,411.34
- Revenue Next Year
- ONMD N/A
- ADAG $28.29
- P/E Ratio
- ONMD N/A
- ADAG N/A
- Revenue Growth
- ONMD N/A
- ADAG N/A
- 52 Week Low
- ONMD $0.30
- ADAG $1.30
- 52 Week High
- ONMD $4.22
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- ONMD 40.51
- ADAG 52.78
- Support Level
- ONMD $1.04
- ADAG $1.78
- Resistance Level
- ONMD $1.52
- ADAG $1.99
- Average True Range (ATR)
- ONMD 0.17
- ADAG 0.20
- MACD
- ONMD -0.04
- ADAG 0.02
- Stochastic Oscillator
- ONMD 36.88
- ADAG 72.85
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's technology has provens the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade, image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols, paving the way for Real World Evidence.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.